Yubo International Biotech Limited
YBGJ
$0.053
$0.00367.29%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -104.87% | -30.96% | |||
| Gross Profit | 104.87% | 30.96% | |||
| SG&A Expenses | -28.15% | 37.86% | |||
| Depreciation & Amortization | -14.52% | 10.71% | |||
| Other Operating Expenses | -65.10% | -36.90% | |||
| Total Operating Expenses | -43.17% | 3.81% | |||
| Operating Income | 43.17% | -3.81% | |||
| Income Before Tax | 43.18% | -3.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 43.18% | -3.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 57.21% | -43.22% | |||
| Net Income | 50.12% | -10.10% | |||
| EBIT | 43.17% | -3.81% | |||
| EBITDA | 45.77% | -3.69% | |||
| EPS Basic | 50.00% | -9.09% | |||
| Normalized Basic EPS | 55.17% | -16.00% | |||
| EPS Diluted | 50.00% | -9.09% | |||
| Normalized Diluted EPS | 55.17% | -16.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
